Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
---|---|---|---|---|---|
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | 13484 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | 23747 | Peak area | MCN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | 44628 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | 77733 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | 363038 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | Peak area | MCN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M+Cl)- | Peak area | SCA | N/A | |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M-H)- | 20954 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M-H)- | 243270 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M-H)- | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M-H)- | Peak area | MCN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | URIDINE (M-H)- | Peak area | SCA | N/A | |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+H)+ | 1298 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+H)+ | 96680 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+H)+ | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+H)+ | Peak area | MCN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+H)+ | Peak area | SCA | N/A | |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+Na)+ | 94637 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+Na)+ | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+Na)+ | Peak area | MCN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | URIDINE (M+Na)+ | Peak area | SCA | N/A |